Archive
Refine by category
Refine by year
2018
2017
2016
2015
2014
2013
12.09.18
Concordia International corp. provides further update on its recently completed recapitalization transaction
Learn More
11.09.18
Concordia International corp. Provides update on its recently completed recapitalization transaction
Learn More
06.09.18
Concordia International corp. completes recapitalization transaction
Learn More
08.08.18
Concordia International corp. announces second quarter 2018 results
Learn More
25.07.18
Concordia International corp. announces release date for second quarter 2018 results
Learn More
19.07.18
Concordia International corp. announces NASDAQ delisting
Learn More
26.06.18
Concordia International corp. obtains final court order approving its recapitalization transaction and announces leadership changes
Learn More
19.06.18
Concordia International corp. announces approval of its CBCA plan of arrangement by its shareholders and debtholders
Learn More
18.06.18
Concordia International corp. announces amendments to its CBCA plan of arrangement in connection with its recapitalization transaction
Learn More
07.06.18
Concordia International corp. announces update on debtholder votes and extension of the early consent date in connection with its recapitalization transaction
Learn More
28.05.18
Concordia International corp. announces changes to its board of directors
Learn More
07.05.18
Concordia International corp. announces release date for first quarter 2018 results
Learn More
02.05.18
Concordia International corp. announces first quarter 2018 results
Learn More
06.04.18
Concordia Healthcare corp. announces name change to Concordia international corp. and comments on Brexit's impact on the company's business
Learn More
15.02.18
Concordia International corp. comments on CMA's decision to close its investigation of Fusidic acid
Learn More
15.12.17
Concordia International corp. comments on recent trading activity
Learn More
21.11.17
Concordia International corp. comments on CMA statement of objections related to Liothyronine
Learn More
01.11.17
Concordia International corp. announces release date for third quarter 2017 results
Learn More
20.10.17
Concordia International corp. takes next step to realign its capital structure by commencing proceedings under the Canada business corporations act
Learn More
16.10.17
Concordia International corp. continues discussions with stakeholders; defers unsecured interest payment due October 16th as it works toward realignment of its capital structure
Learn More
11.10.17
Concordia International corp. announces new communication with CMA
Learn More
06.09.17
Concordia International corp. announces deliver strategy
Learn More
30.08.17
Concordia International corp. announces release date for deliver strategy
Learn More
28.07.17
Concordia International announces release date for second quarter 2017 results
Learn More
21.06.17
Concordia International corp. provides update on development of long-term growth strategy
Learn More
13.06.17
Concordia International corp. announces Redhill Biopharma has started promoting Donnatal® in the U.S.
Learn More
09.06.17
Concordia International corp. announces results of annual general and special meeting of shareholders
Learn More
31.05.17
Concordia International corp. announces results of first CMA stop/go decision
Learn More
04.05.17
Concordia International corp. announces two new appointments to the board of directors
Learn More
02.05.17
Concordia International corp. announces release date for first quarter 2017 results
Learn More
26.04.17
Concordia International appoints David Price as Chief Financial Officer
Learn More
09.03.17
Concordia International corp. announces release date for fourth quarter and year-end 2016 results
Learn More
03.03.17
Concordia International corp. comments on CMA statement of objections related to Hydrocortisone 10mg
Learn More
01.02.17
Concordia International corp. makes final earn out payment to Cinven
Learn More
03.01.17
Concordia International corp. announces co-promote agreement for Donnatal®
Learn More
28.12.16
Concordia International corp. announces leadership transition at international segment
Learn More
19.12.16
Concordia International corp. provides business update
Learn More
02.11.16
Concordia International announces new leadership appointments
Learn More
01.11.16
Concordia International corp. announces second cross currency swap agreement
Learn More
25.10.16
Concordia International corp. announces communication with CMA
Learn More
21.10.16
Concordia International corp. announces CEO transition plan
Learn More
13.10.16
Concordia International announces closing of senior notes offering and appoints Allan Oberman to board of directors
Learn More
06.10.16
Concordia International announces pricing of offering of senior notes
Learn More
05.10.16
Concordia International announces pricing of offering of senior notes
Learn More
03.10.16
Concordia International exercises option to defer portion of earn-out and provides update on strategic review
Learn More
22.08.16
Concordia International corp. issues statement on sale of company stock
Learn More
15.08.16
Concordia International corp. announces cross currency swap agreement
Learn More
03.08.16
Concordia International corp. confirms that strategic review is ongoing and provides update on its business
Learn More
19.07.16
Concordia International announces release date for second quarter 2016 results
Learn More
13.07.16
Concordia International corp. provides additional disclosure in relation to Brexit's impact on its business
Learn More
30.06.16
Concordia International corp. announces FDA approval for new Photofrin® laser
Learn More
17.06.16
Concordia Healthcare announces PDT with Photofrin® data and provides corporate update
Learn More
02.06.16
Concordia Healthcare confirms that review of strategic alternatives ongoing
Learn More
01.06.16
Concordia Healthcare completes acquisition of four generic products
Learn More
29.04.16
Concordia Healthcare reports results of annual general and special meeting of shareholders
Learn More
21.04.16
Concordia Healthcare announces formation of special committee to review strategic alternatives
Learn More
19.04.16
Concordia Healthcare announces release date for first quarter 2016 results
Learn More
29.03.16
Concordia Healthcare corrects inaccurate report
Learn More
16.02.16
Concordia Healthcare announces addition to senior executive team, presentation at RBC investor conference, and release date for fourth quarter and 2015 results
Learn More
15.01.16
Concordia Healthcare to present at CIBC investor conference
Learn More
11.01.16
Concordia Healthcare provides corporate update
Learn More
15.12.15
Concordia Healthcare announces intent to repay US$45 million debt, and inclusion to NASDAQ Biotech index
Learn More
23.11.15
Concordia Healthcare announces launch of first pipeline product, and positive amendment to earn-out terms of AMCO agreement
Learn More
30.10.15
Concordia Healthcare to host third quarter 2015 results conference call
Learn More
30.10.15
Concordia Healthcare's Mark Thompson to appear on business news network today
Learn More
26.10.15
Concordia Healthcare announces preliminary 2016 guidance
Learn More
21.10.15
Concordia Healthcare completes AMCO acquisition
Learn More
21.10.15
Concordia Healthcare's Mark Thompson to appear on BNN today
Learn More
20.10.15
Concordia Healthcare announces pricing of offering of senior notes
Learn More
20.10.15
Concordia provides update on term loan financing and reconfirms blended interest rate of approximately 7.25% post AMCO acquisition
Learn More
15.10.15
Concordia provides update on AMCO financing and capital structure post AMCO acquisition
Learn More
14.10.15
Concordia announces adoption of advance notice by-law
Learn More
09.10.15
Concordia provides update on AMCO acquisition
Learn More
30.09.15
Concordia Healthcare completes us$520 million public offering of common shares at us$65.00 per common share
Learn More
21.09.15
Concordia Healthcare announces public offering of common shares
Learn More
08.09.15
Concordia Healthcare to acquire Amdipharm mercury limited (amco) for us$3.5 billion creating a global platform to facilitate future growth
Learn More
29.07.15
Concordia Healthcare corp. To host second quarter 2015 results conference call
Learn More
10.07.15
Concordia Healthcare announces filing of preliminary base shelf prospectus
Learn More
25.06.15
Concordia Healthcare corp. Reports results of annual general meeting of shareholders
Learn More
25.05.15
Concordia Healthcare announces changes to the board of directors, management team and auditors
Learn More
07.05.15
Concordia Healthcare corp. Works to expand treatment options for patients with rare cancers
Learn More
24.04.15
Concordia Healthcare corp. To host first quarter 2015 results conference call
Learn More
21.04.15
Concordia Healthcare corp. Announces completion of acquisition of Covis Pharma commercial assets for us$1.2 billion
Learn More
08.04.15
Concordia Healthcare corp. Closes c$368 million bought deal financing of subscription receipts
Learn More
06.04.15
Concordia Healthcare corp. Announces proposed private offering of us$610 million senior notes due 2023
Learn More
16.03.15
Concordia Healthcare corp. To host fourth quarter and year-end 2014 results conference call
Learn More
09.03.15
Concordia Healthcare corp. To acquire Covis Pharma commercial assets for us$1.2 billion
Learn More
12.02.15
Concordia Healthcare corp. Provides corporate update
Learn More
24.12.14
Concordia Healthcare announces terms of us$520 million public offering of common shares
Learn More
22.12.14
Concordia Healthcare corp. Announces change to board of directors
Learn More
28.11.14
Concordia Healthcare corp. Provides clinical trial and corporate update
Learn More
23.10.14
Concordia Healthcare corp. To host third quarter 2014 results conference call
Learn More
07.10.14
Pinnacle biologics, inc., a subsidiary of Concordia healthcare corp., announces European site initiation of phase 3 bile duct cancer trial using photodynamic therapy with Photofrin®
Learn More
30.09.14
Concordia Healthcare corp. Announces completion of Zonegran® acquisition
Learn More
03.09.14
Concordia Healthcare announces agreement to acquire Zonegran® in the united states and Puerto Rico
Learn More
02.09.14
Concordia Healthcare corp. Enters into collaboration agreement with orphan Canada
Learn More
13.08.14
Concordia Healthcare corp. Announces financial and operational results for its second quarter, ended June 30, 2014
Learn More
05.08.14
Concordia Healthcare corp. Initiates phase 3 bile duct cancer trial using photodynamic therapy with Photofrin®
Learn More
27.06.14
Concordia Healthcare corp. Reports results of annual general and special meeting of shareholders
Learn More
12.06.14
Concordia Healthcare to present at Bloom Burton & co. Healthcare investor conference
Learn More
15.05.14
Concordia Healthcare announces successful completion of Donnatal® acquisition
Learn More
05.05.14
Concordia Healthcare corp. To host first quarter 2014 results conference call
Learn More
26.03.14
FDA approves optiguide® dcyl700 fiber optic diffuser series flexible fiber
Learn More
24.03.14
Concordia Healthcare corp. To host fiscal 2013 year-end results conference call
Learn More
20.03.14
Concordia Healthcare announces agreement to acquire Donnatal®
Learn More
11.03.14
Concordia Healthcare corp. Closes $67.6 million bought deal financing
Learn More
13.01.14
Concordia Healthcare corp. Announces FDA agreement on special protocol assessment for phase 3 clinical trial on new therapy to treat Perihilar Cholangiocarcinoma
Learn More
06.01.14
Concordia Healthcare corp. Announces exclusive distribution agreement for ulesfia® with Lachlan Pharma holdings
Learn More
30.12.13
Concordia Healthcare corp. Announces filing of ulesfia® with health Canada
Learn More
Show More News